A Carfentanil-Targeted Vaccine Adjuvanted with a Covalent TLR7/8 Agonist and a T-Helper Epitope Confers Protective Immunity against Carfentanil-Induced Effects
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Kaixuan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Laboratory for Frontier Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin130022, C…. Hauptthemen laut MEDLINE: Fentanyl, Toll-Like Receptor 7, Toll-Like Receptor 8, Epitopes, T-Lymphocyte. Die Arbeit nennt 49 Literaturangaben. Gefördert von: International Partnership Program of the Chinese Academy of Sciences, Jilin Province Science and Technology Program, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Carfentanil, an ultrapotent synthetic opioid, poses a severe public health threat because of its rapid brain penetration and potent activation of μ-opioid receptors. Conventional anti-drug vaccines are limited by the poor hapten immunogenicity and dominant anti-carrier immunity. Here, we report a molecularly encoded synthetic carfentanil vaccine (MECVPLA−PEI) integrating a carfentanil hapten, TLR7/8 agonist, and T-helper epitope within a polymeric scaffold to coordinate B and T cell activation. MECVPLA−PEI exhibited markedly enhanced lymph node targeting, with 21.2-fold higher accumulation at 24 h and retention over 7 days, leading to a 1.5-fold increase in plasma cell differentiation and enhanced dendritic cell activation. Compared with an OVA-carrier protein-based vaccine, MECVPLA−PEI induced 22-fold higher antibody titers with a very low level of anti-carrier antibodies and attenuated carfentanil-induced antinociceptive and reward-related behaviors. Importantly, MECVPLA−PEI exhibited a favorable safety profile. This work establishes a precise synthetic vaccine strategy for anti-carfentanil therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Laboratory for Frontier Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui230026, China.
- State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun130022, China.
- Jilin Biomedical Polymers Engineering Laboratory, Changchun130022, China.
ORCID-Profile: Sheng Ma, Hongshuang Wang, Wantong Song, Xiaohui Wang
Förderung
- International Partnership Program of the Chinese Academy of Sciences
- Jilin Province Science and Technology Program
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wang, K., Ma, S., Wang, H., Cheng, H., Song, W., & Wang, X. (2026). A Carfentanil-Targeted Vaccine Adjuvanted with a Covalent TLR7/8 Agonist and a T-Helper Epitope Confers Protective Immunity against Carfentanil-Induced Effects. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01930
Vancouver
Wang K, Ma S, Wang H, Cheng H, Song W, Wang X. A Carfentanil-Targeted Vaccine Adjuvanted with a Covalent TLR7/8 Agonist and a T-Helper Epitope Confers Protective Immunity against Carfentanil-Induced Effects. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01930
BibTeX
@article{Wang2026,
author = {Wang, Kaixuan and Ma, Sheng and Wang, Hongshuang and Cheng, Hongyuan and Song, Wantong and Wang, Xiaohui},
title = {A Carfentanil-Targeted Vaccine Adjuvanted with a Covalent TLR7/8 Agonist and a T-Helper Epitope Confers Protective Immunity against Carfentanil-Induced Effects},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01930}
}
EUVIMED